It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 2 FA rating(s) are green whilePHG’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 5 TA indicator(s) are bullish while PHG’s TA Score has 8 bullish TA indicator(s).
BAX (@Pharmaceuticals: Other) experienced а +5.19% price change this week, while PHG (@Medical/Nursing Services) price change was +4.35% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.29%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +14.72%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.22%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +18.56%.
BAX is expected to report earnings on Oct 30, 2025.
PHG is expected to report earnings on Nov 04, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+1.22% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
BAX | PHG | BAX / PHG | |
Capitalization | 11.9B | 26.9B | 44% |
EBITDA | 1.04B | 2.41B | 43% |
Gain YTD | -19.426 | 21.642 | -90% |
P/E Ratio | 87.85 | 153.06 | 57% |
Revenue | 10.9B | 17.9B | 61% |
Total Cash | 1.69B | 1.82B | 92% |
Total Debt | 9.73B | 8.43B | 115% |
BAX | PHG | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 91 | |
PRICE GROWTH RATING 1..100 | 64 | 48 | |
P/E GROWTH RATING 1..100 | 30 | 9 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (16) in the Electronic Production Equipment industry is in the same range as BAX (20) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BAX’s over the last 12 months.
PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as BAX (100) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BAX’s over the last 12 months.
PHG's SMR Rating (91) in the Electronic Production Equipment industry is in the same range as BAX (93) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BAX’s over the last 12 months.
PHG's Price Growth Rating (48) in the Electronic Production Equipment industry is in the same range as BAX (64) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BAX’s over the last 12 months.
PHG's P/E Growth Rating (9) in the Electronic Production Equipment industry is in the same range as BAX (30) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BAX’s over the last 12 months.
BAX | PHG | |
---|---|---|
RSI ODDS (%) | 2 days ago57% | 2 days ago61% |
Stochastic ODDS (%) | 2 days ago52% | 2 days ago56% |
Momentum ODDS (%) | 2 days ago66% | 2 days ago54% |
MACD ODDS (%) | 2 days ago46% | 2 days ago58% |
TrendWeek ODDS (%) | 2 days ago54% | 2 days ago58% |
TrendMonth ODDS (%) | 2 days ago63% | 2 days ago54% |
Advances ODDS (%) | 2 days ago52% | 2 days ago60% |
Declines ODDS (%) | 9 days ago61% | 9 days ago60% |
BollingerBands ODDS (%) | 2 days ago55% | 2 days ago74% |
Aroon ODDS (%) | 2 days ago55% | 2 days ago58% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IEZ | 18.40 | 0.15 | +0.82% |
iShares US Oil Equipment & Services ETF | |||
SIXA | 49.13 | 0.38 | +0.78% |
ETC 6 Meridian Mega Cap Equity ETF | |||
DFGR | 27.40 | 0.12 | +0.44% |
Dimensional Global Real Estate ETF | |||
VNIE | 24.91 | N/A | N/A |
Vontobel International Equity Active ETF | |||
DWSH | 6.89 | -0.06 | -0.79% |
AdvisorShares Dorsey Wright Short ETF |
A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.
Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
---|---|---|---|---|
BAX | 100% | +0.52% | ||
ALGN - BAX | 72% Closely correlated | +0.47% | ||
LUNG - BAX | 53% Loosely correlated | -3.18% | ||
STE - BAX | 51% Loosely correlated | -0.04% | ||
SYK - BAX | 51% Loosely correlated | +1.40% | ||
SOLV - BAX | 50% Loosely correlated | +1.01% | ||
More |
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
---|---|---|---|---|
PHG | 100% | +0.67% | ||
RYLPF - PHG | 56% Loosely correlated | N/A | ||
ALC - PHG | 49% Loosely correlated | -0.38% | ||
BAX - PHG | 40% Loosely correlated | +0.52% | ||
SYK - PHG | 40% Loosely correlated | +1.40% | ||
QGEN - PHG | 40% Loosely correlated | +0.29% | ||
More |